Fluvoxamine Helps Lower Risk of Hospitalization From Covid, Study Finds
A large clinical trial has found that a common and inexpensive antidepressant lowered the odds that high-risk Covid-19 patients would be hospitalized. The results, published on Wednesday, could open the door to new guidelines for the drug’s use both in the United States and globally. The drug, fluvoxamine, has been safely prescribed for nearly 30…